Semaglutide 2.4 mg (Wegovy) and tirzepatide (Zepbound) are approved for adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
In this article, well explore how these two weight loss medications work, compare their dosing and side effects, and discuss what to expect in terms of cost, duration, and overall effectiveness from each option
White powder may indicate absent or incomplete copper complexation
Mahadevan U, Robinson C, Bernasko N et al (2019) Inflammatory bowel disease in pregnancy clinical care pathway: a report from the american gastroenterological association IBD parenthood project working group
However, I find that on an empty stomach the 500 mg tablet causes some stomach discomfort which at times has actually precipitated Atrial Fibrillation, so I have been taking it with meals